Kimia Biosciences gets permission to manufacture, sell new API ‘Brivaracetam’

23 Feb 2021 Evaluate

Kimia Biosciences has been granted permission to manufacture new API for sale or for distribution namely Brivaracetam by Central Drugs Standard Control Organization, Ministry of Health & Family Welfare, FDA Bhawan, New Delhi, dated February 15, 2021 in FORM CT-22 under Drugs & Cosmetics Acts & Rules thereunder. 

Kimia Biosciences is a pharmaceutical company and the state of the art manufacturing facility is manufacturing latest Bulk Drugs and intermediates (R&D based) for India and Overseas markets.

Kimia Biosciences Share Price

31.83 -0.81 (-2.48%)
15-Dec-2025 14:33 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1793.50
Dr. Reddys Lab 1280.50
Cipla 1504.95
Zydus Lifesciences 922.20
Lupin 2088.85
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×